LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

Search

Phreesia Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

31.99 3.9

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

30.85

Max

32.08

Pagrindiniai rodikliai

By Trading Economics

Pajamos

2.5M

-3.9M

Pardavimai

6.3M

116M

Pelno marža

-3.376

Darbuotojai

2,082

EBITDA

2M

4.1M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+6.75% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-09-04

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

301M

1.7B

Ankstesnė atidarymo kaina

28.09

Ankstesnė uždarymo kaina

31.99

Naujienos nuotaikos

By Acuity

20%

80%

35 / 372 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Neutral Evidence

Phreesia Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-08-26 23:56; UTC

Uždarbis

WiseTech Lifts Dividend as Its Annual Profit Rises 30% -- Update

2025-08-26 23:48; UTC

Uždarbis

Woolworths Annual Profit Falls, Cuts Dividend

2025-08-26 23:41; UTC

Uždarbis

WiseTech Lifts Dividend as Its Annual Profit Rises 30%

2025-08-26 23:58; UTC

Uždarbis

China Resources Land: Real-Estate Sector Faces Structural Challenges, but Homebuying Demand Gradually Returning >1109.HK

2025-08-26 23:57; UTC

Uždarbis

China Resources Land: 1H Results Buoyed by Investment Property & Asset Management Business >1109.HK

2025-08-26 23:55; UTC

Uždarbis

China Resources Land 1H Net CNY11.88B Vs. Net CNY10.22B >1109.HK

2025-08-26 23:55; UTC

Uždarbis

China Resources Land 1H Rev CNY94.92B Vs. CNY79.19B >1109.HK

2025-08-26 23:48; UTC

Uždarbis

Karoon Energy Interim Dividend 2.4 Australian Cents/Security

2025-08-26 23:47; UTC

Uždarbis

Karoon Energy 1H Underlying Net Profit US$45 Million, Down 61% on Year

2025-08-26 23:47; UTC

Uždarbis

Karoon Energy 1H Revenue US$308.3 Million, Down 25% on Year

2025-08-26 23:47; UTC

Uždarbis

Karoon Energy 1H Net Profit US$71 Million, Up 15% on Year

2025-08-26 23:46; UTC

Rinkos pokalbiai

Nikkei May Trade in Range Amid US Tariff Uncertainty -- Market Talk

2025-08-26 23:42; UTC

Rinkos pokalbiai

Gold Edges Lower on Possible Position Adjustments -- Market Talk

2025-08-26 23:35; UTC

Uždarbis

Karoon Energy Expects Expenditure of US$80 Million-US$90 Million Over 2030-2034

2025-08-26 23:35; UTC

Uždarbis

Karoon Energy Expects Expenditure of US$55 Million-US$65 Million for Projects in 2026

2025-08-26 23:34; UTC

Uždarbis

Karoon Energy: Baúna Revitalization, Life Extension Projects Initiated

2025-08-26 23:34; UTC

Uždarbis

Karoon Energy: Baúna Project Economic Field Life Extends to 2039

2025-08-26 23:33; UTC

Uždarbis

Karoon Energy Raises Baúna Project 2P Reserves by 13.7 Million Bbls

2025-08-26 23:23; UTC

Uždarbis

WiseTech: FY25 Ebitda Margin Exit Run Rate 52%>WTC.AU

2025-08-26 23:22; UTC

Uždarbis

WiseTech: New CargoWise Commercial Model Ready for Rollout>WTC.AU

2025-08-26 23:21; UTC

Uždarbis

WiseTech Says Integration of e2open Is on Track>WTC.AU

2025-08-26 23:14; UTC

Uždarbis

WiseTech Expects FY26 Ebitda Margin of 40-41%>WTC.AU

2025-08-26 23:13; UTC

Uždarbis

WiseTech Expects FY26 Ebitda Growth of 44-53%>WTC.AU

2025-08-26 23:13; UTC

Uždarbis

WiseTech Expects FY26 Ebitda of $550M-$585M>WTC.AU

2025-08-26 23:13; UTC

Uždarbis

WiseTech Expects FY26 Revenue Growth of 79-85%>WTC.AU

2025-08-26 23:12; UTC

Uždarbis

WiseTech Expects FY26 Revenue of $1.39B-$1.44B>WTC.AU

2025-08-26 23:11; UTC

Uždarbis

WiseTech FY Ebitda Margin Ex-e2open Costs 53%>WTC.AU

2025-08-26 23:11; UTC

Uždarbis

WiseTech FY Ebitda Margin 49% Vs. 48%>WTC.AU

2025-08-26 23:10; UTC

Uždarbis

WiseTech FY Ebitda $381.6M Vs. $325.0M>WTC.AU

2025-08-26 23:09; UTC

Uždarbis

WiseTech Global Declares Dividend of $0.077 >WTC.AU

Akcijų palyginimas

Kainos pokytis

Phreesia Inc Prognozė

Kainos tikslas

By TipRanks

6.75% į viršų

12 mėnesių prognozė

Vidutinis 32.88 USD  6.75%

Aukščiausias 36 USD

Žemiausias 29 USD

Remiantis 12 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Phreesia Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

12 ratings

12

Pirkti

0

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

25.23 / 25.61Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Neutral Evidence

Vidutinės trukmės periodas

Strong Bullish Evidence

Ilgalaikis periodas

Bullish Evidence

Rinkos nuotaikos

By Acuity

35 / 372 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Labai stiprus bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Phreesia Inc

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.